HALO THERAPEUTICS
Halo Therapeutics develops antivirals to prevent users from sickness. It researches on virus shapes and creates fatty acids into medicine to lock them. Halo Therapeutics was founded in 2020 and is based in Bristol, England.
HALO THERAPEUTICS
Industry:
Biotechnology Health Care Life Science Medical Therapeutics
Founded:
2020-12-01
Address:
Bristol, Bristol, City Of, United Kingdom
Country:
United Kingdom
Website Url:
http://www.halo-therapeutics.com
Status:
Active
Contact:
+44 117 403 4035
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
Acthera Therapeutics
Acthera Therapeutics is developing an innovative nanotechnology-based platform for the controlled and targeted drug delivery
AMP Therapeutics - Antimicrobial Peptides
Antimicrobial peptides (AMPs) are found in virtually every species, from microbes to humans.
International Society of Hypertension
The World's Premier Blood Pressure Society.
Lipid Therapeutics
Novel therapies for inflammatory diseases of the digestive system
Current Advisors List
Current Employees Featured
Founder
Official Site Inspections
http://www.halo-therapeutics.com
- Host name: 86.20.226.35.bc.googleusercontent.com
- IP address: 35.226.20.86
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "Halo Therapeutics"
Halo Therapeutics - Crunchbase Company Profile & Funding
Halo Therapeutics develops antivirals to prevent users from sickness. It researches on virus shapes and creates fatty acids into medicine to lock them. Halo Therapeutics was founded in …See details»
Our Approach - Halo Therapeutics
Our approach is entirely patient-centric and focuses on diseases with significant unmet needs that cause maximal negative impact to public health. Disease Intervention Our focus is on …See details»
Investors - Halo Therapeutics
Halo Therapeutics is backed by experienced institutional and private investors. Key investors include the Development Bank of Wales, the KBA group and Science Angels Syndicate. The …See details»
Halo Therapeutics - LinkedIn
Halo Therapeutics Co-founder and CSO Imre Berger is University of Bristol Lead in EPSRC/DHSC's new 10.5Mio GBP Future Vaccine Manufactruing and Research Hub. …See details»
Halo Therapeutics - PitchBook
Halo Therapeutics General Information Description. Developer of a pan-coronavirus antivirals designed for the treatment of the Covid-19 virus. The company advances a pipeline of novel and proprietary pan coronavirus …See details»
Halo Therapeutics - Funding, Financials, Valuation & Investors
Halo Therapeutics develops antivirals to prevent users from sickness. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. Pricing. Resources. ... How …See details»
Halo Therapeutics Ltd - VentureRadar
Dansk Biotek Unknown n/a DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, development and …See details»
Halozyme Therapeutics, Inc. (HALO) - Yahoo Finance Canada
Halozyme Therapeutics, Inc. was founded in 1998 and is headquartered in San Diego, California. Corporate Governance Halozyme Therapeutics, Inc.’s ISS Governance QualityScore as of …See details»
Halozyme Therapeutics, Inc. - Investor Relations
Nov 18, 2024 Contact Us. Tram Bui Vice President, Investor Relations & Corporate Communications 609-359-3016 [email protected] [email protected] [email protected]See details»
Halo Therapeutics - Contacts, Employees, Board Members
Organization. Halo Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 1. Number of …See details»
Bristol-based new biotech company is developing ground …
Apr 16, 2021 The Halo Therapeutics team is currently engaging investors to help finance multiple parallel clinical trials. If approved, the antiviral treatments could potentially start rolling …See details»
Our Pipeline - Halo Therapeutics
OUR PIPELINE & SCIENCE Led by scientists with an elite level track record in drug discovery, we are advancing a pipeline of novel and proprietary therapeutics. PIPELINE DEVELOPMENT …See details»
2021: HaloTherapeutics | Elizabeth Blackwell Institute for Health ...
Halo Therapeutics Ltd is preparing for clinical trials into pivotal, cost-effective antiviral treatments for COVID-19, after discovering a molecule which changes the shape of the virus's spike …See details»
Reinventing the patient experience. | Halozyme
The patient is at the forefront of everything we do at Halozyme. With our disruptive drug delivery technologies and robust commercial portfolio, we are committed to reinventing the patient …See details»
Contract Development and Manufacturing Organization | Halo …
Formulate, develop, and manufacture your finished drug product – especially complex, difficult-to-manufacture therapeutics – with Halo Pharma. With capabilities spanning differentiated …See details»
Halozyme Therapeutics And Pfizer Enter Into A Collaboration To …
Dec 21, 2012 Halozyme Therapeutics, Inc. (HALO) announced today that it has entered into a worldwide Collaboration and License Agreement with Pfizer Inc. (PFE) for the purpose of …See details»
Halozyme Therapeutics, Inc. (HALO) - Yahoo Finance
Find the latest Halozyme Therapeutics, Inc. (HALO) stock quote, history, news and other vital information to help you with your stock trading and investing.See details»
News - Halo Therapeutics
May 18, 2023 Halo Therapeutics make Wales their base for progressing innovative coronavirus nasal spray development. June 8, 2023; Study finds 27% rate of long COVID in infected health …See details»
A therapeutic approach to pantothenate kinase associated ...
2 days ago Background Neurodegeneration with brain iron accumulation (NBIA) is a group of genetic neurological disorders frequently associated with iron accumulation in the basal nuclei …See details»
Key Publications - Halo Therapeutics
Free fatty acid binding pocket in the locked structure of SARS-CoV-2 spike protein Christine Toelzer, Kapil Gupta, Sathish K. N. Yadav, Ufuk Borucu, Andrew D. Davidson, Maia Kavanagh …See details»